File(s) not publicly available
The cost-effectiveness of gemcitabine plus cisplatin chemotherapy versus mitomycin ifosfamide and cisplatin (MIP), etopiside plus cisplatin, and vinorelbine plus cisplatin in the treatment of stages III B and IV non-small cell lung cancer: An Italian perspective
No description available
History
Publication title
Monaldi Archives for Chest DiseaseVolume
51Issue
4Pagination
279-288ISSN
1122-0643Department/School
Menzies Institute for Medical ResearchPublisher
PI-ME EditricePlace of publication
ItalyRepository Status
- Restricted